INTELLIGENT BIO SOLUTIONS INC. — Director's Dealing 2020

Dec 30, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: GBS Inc. (GBS)
CIK: 0001725430
Period of Report: 2020-12-22

Reporting Person: Kempler Leonard Victor (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, par value $0.01 per share	2450	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Warrant	$		Common Stock (2450)		Direct
Series B Warrant	$		Common Stock (2450)		Direct

Footnotes

F1: Includes Series A warrant to purchase 2,450 shares of the Company's common stock at an exercise price equal to $8.50 per share exercisable until the fifth anniversary of the issuance date. This warrant is included in the units of the Company's securities sold in the December 2020 initial public offering (the "IPO").

F2: Includes Series B warrant to purchase 2,450 shares of the Company's common stock and together with the Series A warrants at an exercise price equal to $17.00 per share, exercisable until the fifth anniversary of the issuance date and subject to certain adjustment and cashless exercise provisions as described herein. This warrant is included in the units of the Company's securities sold in the IPO.

F3: Represents 2,450 shares of the Company's common stock included in the units of the Company's securities sold in the This warrant is included in the units of the Company's securities sold in the December 2020 initial public offering (the "IPO").